Cardiologist and genomic-medicine expert Eric Topol makes his case for a future of “medical selfies.”
Raising millions, Editas proved that investors are enthusiastic about gene editing. Now the company has to make its technology work.
Thirteen years after the human genome was sequenced, some remarkable treatments are being developed.
Herceptin, the original genetic drug, showed that not all cancers are alike.
With more data, a pioneer of gene sequencing hopes to unlock the connections between DNA and illness.
Startups focused on Asia are among those aiming to bring precision medicine to far more people.
This week’s most thought-provoking papers from the Physics arXiv.
The auto industry may need to team up to prevent spyware, phishing, and ransomware from infecting your ride.
OpenAI is teaching warehouse robots to do your household chores.
By some measures machine vision is better than human vision. But now researchers have found a class of “adversarial images” that easily fool it.